{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:38:11Z","timestamp":1786581491492,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4083,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1538-7836.2011.04473.x","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T17:20:32Z","timestamp":1313601632000},"page":"2020-2028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Plasminogen activator inhibitor type\u00a0I contributes to protective immunity during experimental Gram\u2010negative sepsis (melioidosis)"],"prefix":"10.1016","volume":"9","author":[{"given":"L.M.","family":"KAGER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"WIERSINGA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.T.H.","family":"ROELOFS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.M.","family":"MEIJERS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"LEVI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Van'T VEER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"van der POLL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei","volume":"4","author":"Wiersinga","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0020","doi-asserted-by":"crossref","first-page":"e900","DOI":"10.1371\/journal.pntd.0000900","article-title":"The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20\u2010year Darwin prospective study","volume":"4","author":"Currie","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0025","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1183\/09031936.04.00140703","article-title":"Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection","volume":"24","author":"Choi","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0030","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/ajrccm.161.2.9712038","article-title":"Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome","volume":"161","author":"Gunther","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0035","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","article-title":"Coagulation and innate immune responses: can we view them separately?","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0045","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2004.00827.x","article-title":"Pleiotropic functions of plasminogen activator inhibitor\u20101","volume":"3","author":"Lijnen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0055","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.4049\/jimmunol.171.4.2057","article-title":"Plasminogen activator inhibitor\u20101 supports IL\u20108\u2010mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL\u20108\/heparan sulfate\/syndecan\u20101 complexes","volume":"171","author":"Marshall","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0060","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.4049\/jimmunol.175.6.4049","article-title":"Regulation of lipopolysaccharide\u2010induced lung inflammation by plasminogen activator inhibitor\u20101 through a JNK\u2010mediated pathway","volume":"175","author":"Arndt","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000542-200702000-00012","article-title":"Increased plasminogen activator inhibitor\u20101 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa","volume":"106","author":"Song","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0070","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood-2003-01-0227","article-title":"Plasminogen activator inhibitor type\u20101 deficiency does not influence the outcome of murine pneumococcal pneumonia","volume":"102","author":"Rijneveld","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thorax.2003.013888","article-title":"Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia","volume":"59","author":"Schultz","year":"2004","journal-title":"Thorax"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.shk.0000144422.32647.b6","article-title":"Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers","volume":"23","author":"Iba","year":"2005","journal-title":"Shock"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.thromres.2005.06.007","article-title":"TAFI and PAI\u20101 levels in human sepsis","volume":"118","author":"Zeerleder","year":"2006","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0038-1646614","article-title":"Plasminogen activator inhibitor\u00a01: a new prognostic marker in septic shock","volume":"61","author":"Pralong","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(90)90326-8","article-title":"Plasminogen activator inhibitor\u00a01 and 2, alpha\u20102\u2010antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease","volume":"57","author":"Brandtzaeg","year":"1990","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0100","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2006-05-025197","article-title":"Plasminogen activator inhibitor type\u00a01 is protective during severe Gram\u2010negative pneumonia","volume":"109","author":"Renckens","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2007.07.011","article-title":"Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections","volume":"27","author":"Lim","year":"2007","journal-title":"Immunity"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1538-7836.2007.02796.x","article-title":"Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis","volume":"6","author":"Wiersinga","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0115","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1371\/journal.pmed.0040248","article-title":"Toll\u2010like receptor\u00a02 impairs host defense in gram\u2010negative sepsis caused by Burkholderia pseudomallei (melioidosis)","volume":"4","author":"Wiersinga","year":"2007","journal-title":"PLoS Med"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0120","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1086\/592220","article-title":"CD14 impairs host defense against gram\u2010negative sepsis caused by Burkholderia pseudomallei in mice","volume":"198","author":"Wiersinga","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0038-1657277","article-title":"A simple, sensitive spectrophotometric assay for extrinsic (tissue\u2010type) plasminogen activator applicable to measurements in plasma","volume":"48","author":"Verheijen","year":"1982","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0130","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.4049\/jimmunol.0901008","article-title":"Urokinase receptor is necessary for bacterial defense against pneumonia\u2010derived septic melioidosis by facilitating phagocytosis","volume":"184","author":"Wiersinga","year":"2010","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0135","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.4049\/jimmunol.168.7.3507","article-title":"Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia","volume":"168","author":"Rijneveld","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0140","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2004-12-4623","article-title":"A thrombomodulin mutation that impairs activated protein\u00a0C generation results in uncontrolled lung inflammation during murine tuberculosis","volume":"106","author":"Weijer","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI0215277","article-title":"Cytokines in innate host defense in the lung","volume":"109","author":"Strieter","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0150","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1172\/JCI116893","article-title":"Plasminogen activator inhibitor\u20101 gene\u2010deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis","volume":"92","author":"Carmeliet","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0155","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood-2008-07-170506","article-title":"Reduced thrombin generation increases host susceptibility to group\u00a0A streptococcal infection","volume":"113","author":"Sun","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0160","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.1439793","article-title":"A surface protease and the invasive character of plague","volume":"258","author":"Sodeinde","year":"1992","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0165","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1086\/656787","article-title":"Therapeutic recombinant murine activated protein\u00a0C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumonia","volume":"202","author":"Schouten","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0170","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1086\/315155","article-title":"Elevated plasma concentrations of interferon (IFN)\u2010gamma and the IFN\u2010gamma\u2010inducing cytokines interleukin (IL)\u201018, IL\u201012, and IL\u201015 in severe melioidosis","volume":"180","author":"Lauw","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0175","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1086\/315271","article-title":"Prognostic value of cytokine concentrations (tumor necrosis factor\u2010alpha, interleukin\u20106, and interleukin\u201010) and clinical parameters in severe melioidosis","volume":"181","author":"Simpson","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0180","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1128\/IAI.67.7.3593-3600.1999","article-title":"Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei","volume":"67","author":"Santanirand","year":"1999","journal-title":"Infect Immun"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1699-0463.1999.tb01526.x","article-title":"Regulation of cell adhesion by PAI\u20101","volume":"107","author":"Loskutoff","year":"1999","journal-title":"APMIS"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0190","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.it.2004.06.004","article-title":"uPA and uPAR in fibrinolysis, immunity and pathology","volume":"25","author":"Mondino","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0195","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4049\/jimmunol.165.3.1513","article-title":"Urokinase receptor\u2010deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection","volume":"165","author":"Gyetko","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2011.04473.x_bb0200","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1538-7836.2005.01311.x","article-title":"The role of plasminogen activator inhibitor type\u00a01 in the inflammatory response to local tissue injury","volume":"3","author":"Renckens","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2011.04473.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622073901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622073901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2011.04473.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:53:27Z","timestamp":1761533607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622073901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1538783622073901"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04473.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasminogen activator inhibitor type\u00a0I contributes to protective immunity during experimental Gram\u2010negative sepsis (melioidosis)","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04473.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}